Attention: theNCI’s COVID-19 in Cancer Patients Study (NCCAPS) is recruiting people with cancer and COVID19, who are receiving cancer treatment, to better understand how both affect treatment and outcomes. Learn more about enrolling:
of COVID-19 in people with cancer. In a natural history study, researchers follow people and collect medical and other information about them over time to learn more about how a disease and its symptoms develop and change. Diagnosis and treatment of a disease are not part of natural history studies. The knowledge gained through this study will help doctors better manage treatment for people with cancer and COVID-19 in the future.
Learn more about the risk factors related to serious illness from COVID-19 in people who are having treatment for cancerFind genetic risk factors and markers of serious illness from COVID-19 in people with cancer
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Study: Treating COVID-19 With Hydroxychloroquine Increases Death RiskAn observational study of 96,000 hospitalized COVID-19 patients shows that those who were treated with hydroxychloroquine were likelier to die
続きを読む »
Large Study Finds No Benefit — and Potential Harm — in Using Hydroxychloroquine for COVID-19'There was no evidence of benefit, and a consistent signal of harm'
続きを読む »
UK COVID-19 Study to Test Experimental Vaccine on 10,000Scientists began testing 1,000 volunteers in an early study, but aim to expand vaccinations to older people and children
続きを読む »
Donated plasma benefits COVID-19 patients in small U.S. studyPatients with severe COVID-19 given plasma from someone who recovered from the disease were more likely to stabilize or need less oxygen support than other similar hospital patients, according to results of a small U.S. study released on Friday.
続きを読む »